Eligibility criteria
Condition
Plaque Psoriasis
Sex
Females and Males
Age
18-99 years
Inclusion criteria
Show details
Clinical diagnosis of chronic plaque type psoriasis for at least 6 months as determined by
the subjects medical history, and confirmation of the diagnosis through physical
examination by the investigator Patients who are scheduled by their dermatologist to
initiate treatment with Etanercept
Exclusion criteria
Show details
Previous or current treatment with antipsoriatic biologic drugs, such as etanercept,
infliximab, adalimumab, ustekinumab, alefacept, efalizumab Chronic or acute infections
requiring intravenous or oral anti-infectives within 14 days prior to the Baseline visit